^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

Super NK cell therapy

i
Associations
Company:
Qihan Biotech
Drug class:
NK cell stimulant
Related drugs:
Associations
Phase 1
Institute of Hematology & Blood Diseases Hospital
Not yet recruiting
Last update posted :
08/11/2023
Initiation :
08/10/2023
Primary completion :
08/31/2026
Completion :
08/31/2026
CD33
|
CD33 positive • CD33 expression
|
cytarabine • fludarabine IV • CD33/CLL1 dual CAR-NK cell • Super NK cell therapy